Agenus and Zydus complete $141m BOT+BAL immunotherapy collaboration deal

After closing, Emeryville and Berkeley manufacturing facilities will transfer to Zydus under the newly formed Zylidac Bio subsidiary. Credit: Piotr Swat / Shutterstock.com.